1. Home
  2. LION vs VCEL Comparison

LION vs VCEL Comparison

Compare LION & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LION
  • VCEL
  • Stock Information
  • Founded
  • LION 1997
  • VCEL 1989
  • Country
  • LION United States
  • VCEL United States
  • Employees
  • LION N/A
  • VCEL N/A
  • Industry
  • LION Movies/Entertainment
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LION Consumer Discretionary
  • VCEL Health Care
  • Exchange
  • LION Nasdaq
  • VCEL Nasdaq
  • Market Cap
  • LION 2.0B
  • VCEL 1.6B
  • IPO Year
  • LION N/A
  • VCEL 1997
  • Fundamental
  • Price
  • LION $6.28
  • VCEL $34.56
  • Analyst Decision
  • LION Buy
  • VCEL Strong Buy
  • Analyst Count
  • LION 10
  • VCEL 6
  • Target Price
  • LION $8.83
  • VCEL $58.60
  • AVG Volume (30 Days)
  • LION 2.0M
  • VCEL 571.1K
  • Earning Date
  • LION 11-06-2025
  • VCEL 11-06-2025
  • Dividend Yield
  • LION N/A
  • VCEL N/A
  • EPS Growth
  • LION N/A
  • VCEL 2045.40
  • EPS
  • LION N/A
  • VCEL 0.13
  • Revenue
  • LION $3,986,900,000.00
  • VCEL $249,119,000.00
  • Revenue This Year
  • LION N/A
  • VCEL $18.35
  • Revenue Next Year
  • LION $21.07
  • VCEL $22.26
  • P/E Ratio
  • LION N/A
  • VCEL $258.55
  • Revenue Growth
  • LION 10.89
  • VCEL 16.13
  • 52 Week Low
  • LION $5.55
  • VCEL $29.24
  • 52 Week High
  • LION $8.50
  • VCEL $63.00
  • Technical
  • Relative Strength Index (RSI)
  • LION 46.68
  • VCEL 47.93
  • Support Level
  • LION $6.14
  • VCEL $35.47
  • Resistance Level
  • LION $6.59
  • VCEL $36.99
  • Average True Range (ATR)
  • LION 0.25
  • VCEL 1.44
  • MACD
  • LION 0.03
  • VCEL -0.06
  • Stochastic Oscillator
  • LION 53.85
  • VCEL 33.62

About LION Lionsgate Studios Corp. Common Shares

Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: